Cite
MLA Citation
Scott Plotkin et al.. “ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTOMATIC MENINGIOMAS.” Neuro-oncology, vol. 20, n.d., p. vi19. http://access.bl.uk/ark:/81055/vdc_100095322132.0x000017